In accordance with attachment 1, the contractor shall determine the antiviral inhibitory activity and cytotoxicity of test molecules against respiratory viruses listed in one or more of the groups…
Ended Awarded Last action
- Contract number
- 75N93019F00132
- Awardee
-
Utah State University UEI SPE2YDWHDYU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $211,936
Award facts
- Opportunity
-
- RFPNIAIDDMIDNIHAI2017091 Solicitation number
- In Vitro Assessments of Antimicrobial Activity Award Notice · Posted Nov 14, 2017
- Contract value 100% obligated
- $211,936.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Logan, UT 84322, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $9,072 | |
| Other Administrative Action | $0 | |
| Change Order | $64,500 | |
| Original award | $138,364 |
About this award
Utah State University, doing business as USU, was awarded a $212,000 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity (IVAAA) multiple award indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this award, USU will determine the antiviral inhibitory activity and cytotoxicity of test molecules against specified respiratory viruses using the test methods outlined in Attachment 1 to identify potentially active compounds. Performance will take place in Logan, Utah over a one year period ending in September 2020. The purpose of this delivery order is to support the NIH/NIAID's research into developing antiviral therapies by screening candidate molecules for activity against important respiratory pathogens.
Description
In accordance with attachment 1, the contractor shall determine the antiviral inhibitory activity and cytotoxicity of test molecules against respiratory viruses listed in one or more of the groups below using the specified test method to identify act
Quick answers
Who was awarded contract 75N93019F00132?
75N93019F00132 was awarded to Utah State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 12, 2019.
How much is contract 75N93019F00132 worth?
The government has obligated $211,936 on 75N93019F00132.
Is contract 75N93019F00132 an order under another contract?
Yes. 75N93019F00132 is a delivery order under 75N93019D00021, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93019F00132 competed?
The extent of competition for 75N93019F00132 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award